Crescera Capital Acquisition Corp.
$10.82-$0.25 (-2.26%)
Crescera Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 36.91% below the high.
NYSE · BITE · USD
Stock price, dividends, earnings
Quote as of Jun 28, 2024, 07:50 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Bite Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 7.41% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bite Acquisition Corp.’s forward annual dividend is $0.40 per share, paid quarterly. The forward yield is 3.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bite Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bite Acquisition Corp. currently lacks substantive business operations. Its primary objective is to execute a strategic business combination, which could involve a merger, share exchange, asset acquisition, or a similar transaction, with one or more target enterprises. Founded in 2020 and based in New York, New York, the company plans to concentrate its search efforts on both traditional and innovative restaurant sectors across North America.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.82-$0.25 (-2.26%)
Crescera Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 36.91% below the high.
$10.67+$0.01 (+0.09%)
Enterprise 4.0 Technology Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.74% below the high.
$21.57+$9.67 (+81.26%)
Genesis Growth Tech Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 55.98% below the high.
$31.34$0.00 (0.0%)
Minority Equality Opportunities Acquisition Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.05% below the high.
$5.65-$1.70 (-23.13%)
Jupiter Wellness Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 56.61% below the high.
$12.60-$0.24 (-1.87%)
DP Cap Acquisition Corp I’s quoted price sits in the lower half of its reported 52-week range, 19.59% below the high.
$11.74-$0.02 (-0.17%)
Valuence Merger Corp. I’s quoted price sits in the upper half of its reported 52-week range, 0.42% below the high.
$6.58-$3.46 (-34.46%)
Concord Acquisition Corp III’s quoted price sits in the lower half of its reported 52-week range, 62.63% below the high.